Gyubeom Chin is Associate Director of the Upstream Process Development Group at Samsung Biologics. Gyubeom has over seven years of experience in drug development services in the biopharmaceutical contract development organization (CDO) industry. He joined Samsung Biologics in 2018 and has led multiple CDO projects for various global clients. Gyubeom also played a pivotal role in multiple internal platform developments. He holds a master’s degree in metabolic engineering from Inha University.